Immunis, Inc. — Form D/A
Immunis, Inc. of Irvine, CA, a company, filed a Form D amendment with the SEC on 2024-10-24. The offering totals $25.0M, of which $20.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-24
- Form: D/A
- Accession: 0002028798-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $20.4M
- Remaining: $4.6M
- Investors: 27
- Date of first sale: 2024-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-517540
Issuer
- Name: Immunis, Inc.
- CIK: 0002028798
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 18301 Von Karman Avenue Suite 350, Irvine, CA, 92612
- Phone: (949) 266-2501
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Hans Keirstead | Director | Irvine, CA |
| Takahide Koda | Director | Irvine, CA |
| Daniel Kraft | Director | Irvine, CA |
| Hans Keirstead | Executive Officer | Irvine, CA |
| Gabriel Nistor | Executive Officer | Irvine, CA |
| Gabriel Nistor | Related Person | Irvine, CA |
| Takahide Koda | Related Person | Irvine, CA |
| Hans Keirstead | Related Person | Irvine, CA |
| Daniel Kraft | Related Person | Irvine, CA |
Other filings by this issuer (2)
More